DeepMind, based in the United Kingdom, believes that AI can save lives. The company has a dedicated unit for entering healthcare and the business is rapidly growing. Now it is seeking the cooperation of the British National Health Service (NHS) People's daily lives, including an App, notify doctors and nurses when a patient's condition occurs, and invest in computer analysis of medical images.
However, according to Bloomberg, DeepMind's privacy and ethics issues also spawned in the healthcare arena, and the resulting controversy is likely to push DeepMind to thwart its ambitious medical industry.
After a one-year investigation, UK regulators ruled in July that Royal Free Hospital, a NHS unit, had provided information on 1.6 million patients in DeepMind for the past five years illegally. DeepMind claimed that this is for the company's first product, Streams, The patient's patient is in danger of moving the software.) Finally, the regulator did not take any penalties for the move to DeepMind, but DeepMind confessed the mistake, saying that for testing it would underestimate the complexity of NHS and other patient-related information.
The DeepMind example deserves deep consideration from other AI research firms, many of whom are currently in the health-care industry, where IBM claims that Watson AI software can help doctors find the best ways to treat cancer, a startup by genetic researcher J. Craig Venter Human Longevity wants to create a tailor-made treatment for each cancer patient.
For these companies, success is more important than profitability, but companies that want to help solve healthcare problems through AI must first prove that they trust them, but when it comes to large technology providers, Trust has been gradually depleted by events, including Russia's involvement in the U.S. presidential election, as well as Apple and Google being kicked out of tax avoidance and the tech industry no longer being considered as good or even neutral entities.
DeepMind, which was founded in 2012, may claim to be a start-up, but it is one of the three Corps that the Big Bang alphabet entered the medical market. The other two are Verily, who are responsible for making medical device software and wanting to find people The identity of Calico. DeepMind as a longevity is set to grow under more rigorous scrutiny.
Mustafa Suleyman, co-founder of DeepMind, plays a key role in pushing DeepMind into the healthcare market, although the company admitted that it will take some time before the commercialization of AI-enabled medical products takes a long time and DeepShield's only real-world product Streams (in cooperation with NHS's algorithm) Patient risk), but did not use AI. DeepMind originally intended to use machine learning techniques to improve the NHS's existing algorithm for detecting acute renal failure (AKI) but never really implemented it.
Despite the ups and downs and controversy DeepMind is still working to stream Streams to NHS hospitals, Suleyman said there are American doctors also expressed interest in Streams, but privacy issues may make DeepMind plans to block the integration of AI from Taunton & The Somerset NHS Foundation Trust is a veiled glimpse of the possibility of using the AI to do anything that is one of the Streams clients.
But Suleyman was not discouraged, he was convinced that the medical market has great value, some time in the future AI has a considerable opportunity to change the entire medical industry, but not today, and now DeepMind has been using Streams advance card bit, is expected for the future The medical community to use AI to lay a solid foundation.
Currently, DeepMind's health care business is still not contributing to its performance. In 2016, the company made 40 million pounds of revenue. There was absolutely no sales from the healthcare industry. The company lost a total of 94 million pounds in that year.